Cervical Myelopathy Secondary to Gout: Case Report.

Rev Bras Ortop (Sao Paulo)

Departamento de Ortopedia e Traumatologia, Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, SP, Brasil.

Published: December 2020

Gout is a crystalline arthropathy frequent in the population, but gouty spondyloarthropathy, also called axial gout, is uncommon. The current case report presents a rare case of cervical myelopathy secondary to axial gout. A 50-year-old female patient, without previous pathologies, presented with loss of strength, altered sensitivity, and pyramidal release for 2 years. The computed tomography showed a lytic image in the spinous process of C7, and signs of myelopathy with myelomalacia on magnetic resonance imaging of the cervical spine. After the surgical procedure and biopsy of the material, the diagnosis was gout, and treatment for the pathology was started, with complete improvement of the condition. The diagnosis of axial gout should be included in the spectrum of the differential diagnosis of diseases that affect the spine. Although gouty spondyloarthritis (or spondylitis) is uncommon, there is an underestimated occurrence due to the lack of investigation of the cases. The early diagnosis and treatment of the pathology can prevent patients from presenting complications of the disease, as reported in the present study.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748924PMC
http://dx.doi.org/10.1055/s-0040-1708514DOI Listing

Publication Analysis

Top Keywords

axial gout
12
cervical myelopathy
8
myelopathy secondary
8
case report
8
treatment pathology
8
gout
6
secondary gout
4
gout case
4
report gout
4
gout crystalline
4

Similar Publications

Advances in the management of psoriatic arthritis in adults.

BMJ

November 2024

University of Toronto, Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, Toronto, ON, Canada

Article Synopsis
  • * Management starts with assessing the patient's skin and joints while screening for other health issues, followed by a mix of therapies like education, lifestyle changes, and physiotherapy.
  • * Treatment options include non-steroidal anti-inflammatory drugs and disease-modifying therapies such as methotrexate and biologics, but there’s a need for better biomarkers to personalize these treatments for each patient.
View Article and Find Full Text PDF

Spinal Gout: An Unusual Cause of Low Back Pain.

J Prim Care Community Health

August 2024

Mayo Clinic, Rochester, MN, USA.

Low back pain is the most common musculoskeletal complaint accounting for over 30 million visits to primary care physicians annually. Serious pathology is found in less than 1% of these visits. Therefore it is often a challenge to distinguish worrisome findings requiring further workup and treatment from common complaints of pain.

View Article and Find Full Text PDF

Calcium pyrophosphate deposition disease.

Lancet Rheumatol

November 2024

Academic Rheumatology, University of Nottingham, Nottingham, UK; NIHR Nottingham Biomedical Research Centre, Nottingham, UK.

Article Synopsis
  • - Calcium pyrophosphate deposition disease (CPPD) occurs when CPP crystals build up in joints, triggering inflammation and arthritis, particularly in older individuals over 60, and is linked to cartilage deterioration and osteoarthritis.
  • - Common risk factors for CPPD include aging, past joint injuries, and certain metabolic conditions or genetic factors. Diagnosis relies on detecting CPP crystals in joint fluid and imaging techniques like X-rays and ultrasound.
  • - Current treatment focuses on managing inflammation since there’s no cure for dissolving CPP crystals; options include prednisone for acute arthritis, low-dose colchicine, and potential use of biologics for stubborn cases.
View Article and Find Full Text PDF

Gout of the Axial Skeleton.

Isr Med Assoc J

August 2024

Rheumatology Unit, Bnai Zion Medical Center, Haifa, Israel, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

View Article and Find Full Text PDF

[Rheumatology: what's new in 2023].

Rev Med Suisse

January 2024

Service de rhumatologie, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14.

Article Synopsis
  • - This year in rheumatology has seen advancements in understanding rheumatoid arthritis and low back pain mechanisms, improving diagnosis and management strategies.
  • - Key studies were released on gout, axial spondyloarthritis, autoinflammatory diseases, and systemic vasculitides, along with updated treatment guidelines from ASAS-EULAR and EULAR/PReS.
  • - New safety data on JAK inhibitors emerged, as well as innovative glucocorticoid-sparing strategies for treating giant cell arteritis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!